Namit Joshi

Namit Joshi is the chairman of the Pharmaceutical Export Promotion Council of India, an organization focused on promoting the interests of India's pharmaceutical exporters. He has been actively involved in discussions regarding the impact of international trade policies on the pharmaceutical sector, particularly in relation to the United States. In a recent news context, Joshi commented on how proposed tariffs by the Trump administration would likely not have an immediate impact on Indian pharmaceutical exports, as the majority of India's contributions to the US market are in the form of simple generics, which have different dynamics compared to branded drugs.